We hereby submit the declaration w.r.t. non applicability of regulation 23(9) of SEBI LODR
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
iSERA Lifesciences Limited (formerly Covidh Technologies Ltd) has informed BSE that it is exempt from compliance with Regulation 23(9) of SEBI (LODR) Regulations, 2015. The exemption is claimed under Regulation 15(2), which applies to small companies. As of 31 March 2026, the company's paid-up equity share capital is below ₹10 crore and net worth is below ₹25 crore, qualifying it for this exemption. This is a routine regulatory compliance intimation and does not indicate any financial distress. The company remains listed on BSE with scrip code 534920.
This filing has no direct impact on shareholders or stock price. It is a standard notification confirming the company qualifies as a small-cap exempt entity under SEBI rules, reducing its disclosure obligations.